Artificial intelligence unifies knowledge and actions in drug repositioning

Area of Science:

• Pharmacology and Drug Discovery
• Computational Biology and Bioinformatics

Background:

• Drug repositioning offers a faster, safer alternative to novel drug development by utilizing existing compounds.
• Challenges in traditional drug repositioning include identifying suitable candidates and predicting efficacy for new indications.

Purpose of the Study:

• To review the role of Artificial Intelligence (AI) in accelerating drug repositioning processes.
• To explore how AI integrates knowledge and experimental data for therapeutic identification.
• To share expectations for the future of AI in drug repositioning.

Main Methods:

• Literature review of AI applications in drug repositioning.
• Analysis of AI's role in unifying knowledge and actions for therapeutic discovery.
• Examination of various AI-driven drug repositioning methodologies.

Main Results:

• AI significantly speeds up the identification of effective therapeutics for various diseases.
• AI enables the integration of diverse datasets (real-world, experimental) for improved drug repurposing.
• AI plays a crucial role in multiple drug repositioning strategies.

Conclusions:

• AI is a transformative technology for drug repositioning, enhancing efficiency and success rates.
• The synergy between AI and drug repositioning promises to expedite the delivery of treatments to patients.
• Continued advancements in AI are expected to further revolutionize therapeutic discovery.